Healthcare -
Biotechnology - NASDAQ - CH
$ 44.04
0.273 %
$ 3.78 B
Market Cap
-10.15
P/E
Price Target
Average
65.19%
Revenue Forecast
Estimate
193.52%
EBIT
Estimate
--37.29%
Net Income
Estimate
34.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
CRISPR Therapeutics AG
Wall Street analysts predict an average 1-year price target for CRSP of $72.8 , with forecasts ranging from
a
low of
$52 to a high of $100 .
CRSP Lowest Price Target
Wall Street Target
52 USD
18.07%
CRSP Average Price Target
Wall Street Target
72.8 USD
65.19%
CRSP Highest Price Target
Wall Street Target
100 USD
127.07%
REVENUE FORECAST
Revenue Forecast Chart CRSP
EBIT FORECAST
EBIT Forecast Chart CRSP
NET INCOME FORECAST
Net Income Chart CRSP